Swiss prosecutors will not pursue Novartis over Trump lawyer payments
Novartis admitted that it had signed a one-year contract with the company of Trump’s private lawyer, Michael Cohen.
Keystone
The Office of the Attorney General of Switzerland (OAG) announced on Wednesday that it will not bring proceedings against Novartis in connection with the payments the Swiss pharmaceutical company made to Donald Trump’s personal lawyer.
This content was published on
1 minute
SDA-ATS/ln
The OAGExternal link had received a criminal complaint alleging that Novartis had bribed a foreign public official by paying CHF1.2 million ($1.2 million) to Trump’s lawyer Michael Cohen in 2017.
Novartis admitted in May that it had signed a one-year contract with the company of Trump’s private lawyer to gain insights into the US administration’s thinking on healthcare issues. The company used the same bank account for the payments that was also used in the Stormy Daniels case.
The OAG said it would not open criminal proceedings against the company because there was not sufficient evidence of bribery. The payments could not be linked to a breach of duty on the part of the recipient, therefore the conditions for Novartis’ criminal liability were not fulfilled.
The offence of undue influence does not exist in Swiss law.
The OAG said it would reserve the right to re-examine the situation should new evidence emerge.
More
More
Greek politicians named in Novartis scandal
This content was published on
Greece’s parliament has linked ten prominent politicians to a bribery scandal involving Swiss drug-maker Novartis.
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
How is your country dealing with the return of stolen artifacts?
Western nations like Switzerland often have to deal with the process of recovering or returning looted artifacts which have been illegally imported. What’s the situation like in your country?
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Wanted: Pharma super cops
This content was published on
Have experience in tackling cybercrime, extremism, extortion, blackmail and bribery? If yes, the Swiss pharma industry might want to hear from you.
This content was published on
The Swiss pharmaceutical giant Novartis has announced that it plans to cut 500 jobs at its Basel headquarters in Switzerland over the next 18 months.
This content was published on
The company formed when Ciba Geigy and Sandoz merged and analysts say it’s a big success. The merger cost around 10,000 jobs but in the long-run more were created. The current CEO concedes that the merger also meant the loss of the Ciba corporate identity. Novartis’ profits shrank by a third in 2015, partly because…
Terrorism and financial crimes keep Attorney General busy
This content was published on
The Swiss Attorney General took on 237 new investigations in 2017, mainly linked to international economic crimes and terrorism.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.